Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the structural pricing-power and consumables-annuity evidence is unusually well-documented (18/18 guidance beats, gross margin compounding 47%→70% across every cycle since FY2009, FY09 trough operating margin of +0.1% on a 42% revenue drop), but the market is paying a 49× trailing P/E for FY26 margins (42.3%) that are 12 points above the FY18 prior peak. Both sides agree on the facts; they disagree on which line in the historical chart is the new normal. The decisive tension is whether FY2026's 42.3% operating margin is a structural re-flooring of the franchise or a peak that will retrace toward the FY19 trough of 26.2%. The evidence that would resolve it is observable inside two earnings cycles: a trough-cycle margin print holding above 38% confirms the bull; a sub-38% print without a revenue contraction confirms the bear. Bull edges ahead on weight of evidence, but the multiple does not leave room to be wrong, so the responsible position is to lean into the thesis only after Q1 FY27 (July 2026) translates the +18.8% shipment guide into reported margin durability.

Bull Case

Price target: ¥90,000 (≈42% upside from ¥63,500) — 50× FY28 EPS of ¥1,800, defensible against LRCX (71×), KLAC (60×), ASML (46×) and AMAT (52×) for the highest-gross-margin asset in the peer set. Timeline: 18 months (October 2027), through the FY27 full-year print. Disconfirming signal: two consecutive quarters of absolute consumables revenue decline OR four-year cumulative ordinary margin falling below 35% (vs current 41.4%) — either breaks the razor-blade-floor claim that anchors the multiple.

Bear Case

Downside target: ¥45,000 (~29% below ¥63,500) — peer-multiple compression to KLAC's 23× EV/EBITDA applied to ¥210B FY27 EBITDA, plus ¥285B net cash divided by 108.5M shares ≈ ¥47,000, rounded down for likely consensus EBITDA cuts. Timeline: 12-18 months, through the Q3 FY28 print. Cover signal: a trough-cycle (revenue down ≥15% YoY for two consecutive quarters) operating margin print holding above 38% — i.e., proof that the consumables annuity has structurally re-floored above the FY2019 26.2% level and the 42% peak is not cyclical.

The Real Debate

Verdict

Verdict: Lean Long, Wait For Confirmation. Bull carries more weight because the structural evidence — 18/18 guidance beats, monotonic gross-margin compounding across two full cycles, FY09 operating margin of +0.1% on a 42% revenue drop, a 20-point operating-margin gap over Accretech on the same cost base and customer set — is unusually specific and historically demonstrated, while the bear case rests largely on the proposition that a 49× multiple cannot survive any pause in beat cadence. The single most important tension is whether FY2026's 42.3% operating margin is the new structural floor or a peak that mean-reverts toward the FY19 trough of 26.2%; everything else (valuation, hybrid bonding, receivables) is downstream of that one variable. The bear could still be right because the multiple has no margin of safety, hybrid-bond architecture is a real structural threat that does not respect the share-of-thinning statistic, and DSO has begun drifting at the worst possible point in the cycle. The durable thesis-breaker is a trough-cycle margin print below 38% — that would invalidate the consumables-annuity claim that anchors the multiple. The near-term evidence marker is the Q1 FY27 report in July 2026, which converts the +18.8% shipment guide into reported margin and reveals whether DSO retreats or pushes through 55 days; only after that print confirms margin durability and AR normalization should conviction step up.